Innovations and recent trends in the treatment of ADHD. (Q36607357)

15 August 2017

1 reference

title

Innovations and recent trends in the treatment of ADHD. (English)

1 reference

15 August 2017

Vishal Madaan

1

1 reference

15 August 2017

Shannon Kinnan

series ordinal

2

1 reference

15 August 2017

Joan Daughton

series ordinal

3

1 reference

15 August 2017

Christopher J Kratochvil

series ordinal

4

1 reference

15 August 2017

publication date

1 September 2006

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

15 August 2017

published in

1 reference

15 August 2017

volume

6

1 reference

15 August 2017

issue

9

1 reference

15 August 2017

page(s)

1375-1385

1 reference

A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Absence of gender effects on attention deficit hyperactivity disorder: findings in nonreferred subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Molecular genetics of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Attention-deficit/hyperactivity disorder pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Twin study of the etiology of comorbidity between reading disability and attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Attention-deficit/hyperactivity disorder: a selective overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Can inattention/overactivity be an institutional deprivation syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Differential patterns of striatal activation in young children with and without ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Ten-year review of rating scales. V: scales assessing attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Psychiatric and psychological morbidity as a function of adaptive disability in preschool children with aggressive and hyperactive-impulsive-inattentive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

A dose-ranging study of a methylphenidate transdermal system in children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Methylphenidate transdermal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Modafinil : a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Modafinil in children with attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Zinc in attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371]

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

GW320659 for the treatment of attention-deficit/hyperactivity disorder in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Six-week open-label reboxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1375

10.1586/14737175.6.9.1375

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference